Considerations of pharmacogenetic testing in children.
Publication
, Journal Article
Haga, SB; Solomon, BD
Published in: Pharmacogenomics
June 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
June 2016
Volume
17
Issue
9
Start / End Page
975 / 977
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- Pharmacogenomic Testing
- Pharmacogenetics
- Pediatrics
- Medication Errors
- Humans
- Drug-Related Side Effects and Adverse Reactions
- Child
- 3214 Pharmacology and pharmaceutical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Haga, S. B., & Solomon, B. D. (2016). Considerations of pharmacogenetic testing in children. Pharmacogenomics, 17(9), 975–977. https://doi.org/10.2217/pgs-2016-0073
Haga, Susanne B., and Benjamin D. Solomon. “Considerations of pharmacogenetic testing in children.” Pharmacogenomics 17, no. 9 (June 2016): 975–77. https://doi.org/10.2217/pgs-2016-0073.
Haga SB, Solomon BD. Considerations of pharmacogenetic testing in children. Pharmacogenomics. 2016 Jun;17(9):975–7.
Haga, Susanne B., and Benjamin D. Solomon. “Considerations of pharmacogenetic testing in children.” Pharmacogenomics, vol. 17, no. 9, June 2016, pp. 975–77. Pubmed, doi:10.2217/pgs-2016-0073.
Haga SB, Solomon BD. Considerations of pharmacogenetic testing in children. Pharmacogenomics. 2016 Jun;17(9):975–977.
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
June 2016
Volume
17
Issue
9
Start / End Page
975 / 977
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- Pharmacogenomic Testing
- Pharmacogenetics
- Pediatrics
- Medication Errors
- Humans
- Drug-Related Side Effects and Adverse Reactions
- Child
- 3214 Pharmacology and pharmaceutical sciences
- 3105 Genetics